Hologic, a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, has introduced NovaSure system, a 90-second, minimally-invasive, outpatient treatment for women suffering from excessive menstrual bleeding.
Hologic said that the next generation NovaSure system is designed to offer the same customised technology as trusted by physicians across the US, but with even more control and confidence for the physician and more comfort for the patient. The NovaSure procedure reduces or eliminates excessive bleeding by safely removing the endometrial lining of the uterus responsible for menstrual bleeding.
According to Hologic, the NovaSure procedure provides an effective and minimally invasive alternative to hysterectomy, while avoiding the potential side effects and long-term risks of hormonal drug therapy.
Steve Williamson, senior vice president and general manager at Hologic GYN Surgical Products, said: “We have worked closely with our customers to incorporate a number of physician and patient-focused enhancements resulting in a device designed to offer more leverage and control with significantly less manipulation. This next generation system is designed to provide the physician with improved procedure efficiency and offer the patient even greater comfort.
“More than one million women have been treated with the NovaSure procedure. We believe the new NovaSure enhancements will expand the number of women who are offered the NovaSure procedure as a solution for excessive menstrual bleeding.”